Latest Breaking News On - Universidad complutense ciberonc - Page 1 : comparemela.com

The combination of durvalumab plus etoposide and cisplatin/carboplatin should now become the standard of care for the first-line treatment of extensive-stage small cell lung cancer (ES-SCLC).

Universidad complutense ciberoncAlfredo addeoLuis pazUniversity hospitalLuis paz aresMedical oncology congressLuniversidad complutenseLung cancerUng carcinomaAncer lungSmall cell lung cancerAnti ctla4 antibodiesNti ctla 4 antibodiesNti cytotoxict lymphocyte associated antigen 4 antibodiesMalignant melanoma